Principal Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.6M Buy
911,627
+626,492
+220% +$7.3M 0.01% 1233
2025
Q1
$2.12M Buy
285,135
+141,691
+99% +$1.05M ﹤0.01% 1759
2024
Q4
$860K Buy
+143,444
New +$860K ﹤0.01% 1892
2024
Q3
Sell
-17,495
Closed -$63.3K 2225
2024
Q2
$63.3K Sell
17,495
-15,009
-46% -$54.3K ﹤0.01% 2262
2024
Q1
$104K Sell
32,504
-459,615
-93% -$1.48M ﹤0.01% 2269
2023
Q4
$2.41M Sell
492,119
-754,745
-61% -$3.7M ﹤0.01% 1748
2023
Q3
$6.8M Sell
1,246,864
-8,259
-0.7% -$45K ﹤0.01% 1413
2023
Q2
$8.42M Buy
1,255,123
+7,992
+0.6% +$53.6K 0.01% 1333
2023
Q1
$11M Sell
1,247,131
-9,780
-0.8% -$86.4K 0.01% 1206
2022
Q4
$9.6M Sell
1,256,911
-57,368
-4% -$438K 0.01% 1256
2022
Q3
$9.36M Buy
1,314,279
+113,217
+9% +$806K 0.01% 1222
2022
Q2
$9.72M Buy
1,201,062
+685,171
+133% +$5.54M 0.01% 1273
2022
Q1
$7.16M Buy
515,891
+34,064
+7% +$473K ﹤0.01% 1521
2021
Q4
$13.5M Buy
481,827
+8,059
+2% +$226K 0.01% 1228
2021
Q3
$16.1M Buy
473,768
+12,059
+3% +$410K 0.01% 1108
2021
Q2
$18.9M Buy
461,709
+109,380
+31% +$4.47M 0.01% 1023
2021
Q1
$14.2M Buy
352,329
+29,042
+9% +$1.17M 0.01% 1187
2020
Q4
$19.1M Buy
323,287
+6,213
+2% +$367K 0.01% 802
2020
Q3
$15.4M Buy
317,074
+109,027
+52% +$5.3M 0.01% 803
2020
Q2
$10.1M Buy
208,047
+138,977
+201% +$6.72M 0.01% 1052
2020
Q1
$1.92M Sell
69,070
-4,800
-6% -$133K ﹤0.01% 1608
2019
Q4
$2.21M Buy
73,870
+3,743
+5% +$112K ﹤0.01% 1711
2019
Q3
$2.17M Sell
70,127
-9,873
-12% -$305K ﹤0.01% 1706
2019
Q2
$3.86M Buy
+80,000
New +$3.86M ﹤0.01% 1602